for lung squamous cell carcinoma resistant to FGFR1 inhibitors, FGFR1 inhibitor BGJ398 was combined with MEK inhibitor (trametinib) or PI3K inhibitor (BKM120) to overcome the single-drug resistance. The gene discussed is FGFR1; the disease is squamous cell lung carcinoma.